Literature DB >> 14583066

Declaration of fructose and fructose-related adverse effects in commercial drug preparations in European countries.

Arne Reimers, Olav Spigset.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14583066     DOI： 10.2165/00002018-200326140-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  5 in total

1.  Topiramate and hepatotoxicity.

Authors:  R J Doan; M Clendenning
Journal:  Can J Psychiatry       Date:  2000-12       Impact factor: 4.356

2.  Topiramate and fulminant liver failure.

Authors:  K Bjøro; L Gjerstad; O Bentdal; S Osnes; E Schrumpf
Journal:  Lancet       Date:  1998-10-03       Impact factor: 79.321

3.  [Fatal consequences of fructose infusion in undiagnosed fructose intolerance].

Authors:  M Rey; R Behrens; G Zeilinger
Journal:  Dtsch Med Wochenschr       Date:  1988-06-10       Impact factor: 0.628

4.  [Acute liver and kidney failure following sorbitol infusion in a 28-year-old patient with undiagnosed fructose intolerance].

Authors:  S Locher
Journal:  Anasth Intensivther Notfallmed       Date:  1987-08

5.  Topiramate enhances the risk of valproate-associated side effects in three children.

Authors:  Elke Longin; Martin Teich; W Koelfen; Stefan König
Journal:  Epilepsia       Date:  2002-04       Impact factor: 5.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.